Electronic Clinical Outcome Assessment Solutions Market Size, Share & Trends Analysis Report By Delivery Mode (Web & Cloud Based, On-premise), By End-user, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

According to Nova one advisor, the global Electronic Clinical Outcome Assessment Solutions Market Size was valued at USD 1.56 billion in 2022 and is predicted to be worth USD 8.12 billion by 2032, with a CAGR of 19.1% from 2023 to 2032. 

Key Takeaways:

• The electronic clinical outcome assessment (eCOA) solutions market was valued at USD 1.36 billion in 2022 and is expected to expand at a CAGR of 15.2% during the forecast period
• Web &Cloud-based solutions are anticipated to grow at an exponential rate owing to the integrated features that include flexibility, high accessibility, negligible handling costs, and easy data backup. The added advantage of remote access to information also contributes to segment growth
• Contract research organizations dominated the eCOA solutions market as major pharmaceutical companies are focused on reducing expenditure on clinical trials
• North America held the largest market share owing to the local presence of well-established market players coupled with large number of ongoing research in this region
• Asia Pacific market is expected to show fastest growth during the forecast period owing to the increasing clinical research activities by the end users such as CROs and biopharmaceutical companies
• The companies are making significant investments to implement eClinical solutions in order to manage medical information, owing to the benefits it offers

The key factors driving the market growth include increasing interoperability across eClinical solutions, surge in adoption owing to the COVID-19, use of telehealth, need to comply with changing regulations, and increasing complexity of data generated in clinical research.

The COVID-19 led to operational hurdles in clinical research activities including clinical trials. This included postponement of trials, recruitment challenges, and management problems. The pandemic, however, accelerated the adoption of enabling technologies for managing clinical trial operations and data. This boosted demand for the eClinical solutions including electronic clinical outcome assessment (eCOA) solutions. As patients were unable to visit trial sites, eCOA solutions emerged as a reliable solution to collect patient data. It also helped sites maintain compliance during the pandemic. For instance, IQVIA reported that its eCOA platform was deployed multiple times during the pandemic in clinical trials.

The complexity in healthcare information management is anticipated to fuel demand for the eCOA solutions in coming years. These solutions deliver accurate and timely health information and reduce burden of the patients enrolled in clinical trials. eCOA measures overall mental state, patient symptoms, and the progression of a disease. Electronic diaries and electronic patient reported outcomes (ePRO) are a part of eCOA platforms. Electronic diaries help document patient response. These are used as support systems for ePRO. eCOA solution from Cloudbyz for instance, includes ePRO and eDiary functionalities and supports electronic clinical outcome data, captured with compliance adherence.

In addition, assessments systems help detect probable adverse conditions in advance for the patients, which is crucial for taking preventive measures to avoid adverse effects in future. The ePRO platforms transfer real-time data from the patients to healthcare professionals for accurate decision-making and better evaluation of a patient’s health. Thus, the adoption of these platforms is expected to grow in near future. Growing adoption of software solutions during research studies, high R&D expenditure by the pharmaceutical companies, favorable government grants to support clinical trials, and widening base of potential customers are some of the key contributing factors for the market growth.

Report Scope of the Electronic Clinical Outcome Assessment Solutions Market

Delivery Mode Insights

Web & cloud-based segments contributed to the largest revenue share of the eCOA solutions market by delivery mode in 2022. This is owing to the associated benefits of its usage. Remote access to the patient’s health information and sharing of the information to limit potential misuse of the data or address the problems at a critical point of study are some of the key features offered by these solutions. Other benefits include centralization of data, scalability, reduced costs, and uptime consistency.

On-premise solutions, on the other hand, may be preferred for their localization of data, data security, and more control over data. The high cost of implementation and infrastructure may restrain the segment growth. An increasing number of companies and initiatives deployed by them are expected to fuel market growth. Some of the key companies include IBM, IQVIA Inc., Medidata Solutions, Inc., Clario, ArisGlobal, Signant Health, and others.

End-user Insights

Contract research organizations (CROs) held the largest revenue share in 2021 and are expected to witness significant growth in the near future due to the outsourcing of clinical research management by major biopharmaceutical and medical device companies. IQVIA eCOA for example supports real-time patient data collection in real-world studies and clinical research. During the COVID-19 the solution was deployed across several trials to enable real-time data capture, cost-effectively and remotely.

Hospitals and healthcare providers are adopting electronic data-capturing services to improve patient engagement in research studies, as eCOA digitally collects information from both patients and doctors. eCOA captures information on handheld devices such as smartphones & tablets, interactive voice response systems, browsers, and patients’ Bring-Your-Own-Device (BYOD).

It utilizes secure systems that meet the regulatory guidelines for capturing clinical data. The adoption of mHealth devices and the introduction of advanced technologies for patient care, such as BYOD, are the key growth propellers for the implementation of eCOA solutions in hospitals.

Regional Insights

North America was estimated to be the largest regional market in 2022. The presence of technologically advanced research centers, medical device manufacturers, universities, and hospitals coupled with improved healthcare establishments are expected to drive new drug development activities in the coming years. The U.S. accounted for the largest market share of North America in 2022, owing to the higher adoption levels of eClinical solutions.

Initiatives and acquisitions pertaining to the adoption of eClinical platforms undertaken by key end-users and market players are anticipated to boost usage in the coming years. For instance, the press release from Dacima in July 2022 stated that EvidentIQ acquired Dacima. As a result, the EvidentIQ Group now has access to Dacima's broad service offering for end-to-end eClinical solutions which includes eCOA.

Asia Pacific is growing in terms of large patient pools, outsourcing, and the flow of investment by MNCs and CROs to support clinical research and drug discovery. This is projected to enhance the market growth. India and China are the key markets for clinical research outsourcing for major pharma & biotech companies. This is anticipated to be a key contributing factor toward the rising demand for eCOA solutions during the forecast period.

Some of the prominent players in the Electronic Clinical Outcome Assessment Solutions Market include:

• IBM
• IQVIA Inc.
• Medidata Solutions, Inc.
• Clario
• ArisGlobal
• Signant Health
• TransPerfect
• Cloudbyz
• Clime do Health GmbH
• ClinCapture

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Electronic Clinical Outcome Assessment Solutions market.

• Delivery Mode

• On-premise
• Web & Cloud-based
• End-user
• Hospitals/Healthcare Providers
• CROs
• Pharmaceutical & Biotechnology Firms
• Medical Device Companies
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Electronic Clinical Outcome Assessment Solutions industry analysis from 2023 to 2032 to identify the prevailing Electronic Clinical Outcome Assessment Solutions industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Electronic Clinical Outcome Assessment Solutions industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Electronic Clinical Outcome Assessment Solutions industry trends, key players, market segments, application areas, and market growth strategies.